Canada Implements New Importing Regulations for Opioid Crisis

The Government of Canada is taking prompt action to make more treatment options available for the opioid crisis and other emergency situations by quickly implementing new regulations that allow the import of medications that are urgently needed in Canada.

Today, Health Canada published an initial List of drugs for an urgent public health need that are authorized for sale in the United States, the European Union or Switzerland, but are not yet authorized in Canada. Health Canada will now permit these drugs to be imported into Canadian jurisdictions that have notified Health Canada of an urgent public health need.

To access a drug through this new process, public health officials need to notify Health Canada of the urgent public health need, and provide key information on the drug and how it is expected to help address the public health crisis in their jurisdiction. The name and other details of the drug will then be published on the List. Licence holders will be able to import and wholesale a drug on the List to the provinces or territories that requested it.

Drugs will remain on the List for one year, after which they would be removed unless Health Canada received a notification for continued access to the drug to address an urgent or continuing public health need. As with any drug sold in Canada, Health Canada will be able to issue a recall to protect the health and safety of Canadians should a safety concern arise.

Read the full article here.

Tagged with

Published 30. June 2017 in News Canada